Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 14;11(4):468.
doi: 10.3390/children11040468.

A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk

Affiliations

A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk

Cristian Nicolae Chirilă et al. Children (Basel). .

Abstract

Hypertensive disorders of pregnancy (HDPs) represent a significant source of severe maternal and fetal morbidity. Screening strategies relying on traditional medical history and clinical risk factors have traditionally shown relatively modest performance, mainly in the prediction of preeclampsia, displaying a sensitivity of 37% for the early-onset form and 29% for the late-onset form. The development of more accurate predictive and diagnostic models of preeclampsia in the early stages of pregnancy represents a matter of high priority. The aim of the present paper is to create an effective second trimester prediction algorithm of early-onset HDP occurrence and severity, by combining the following two biochemical markers: a soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio and uterine artery Doppler ultrasound parameters, namely the pulsatility index (PI) and the resistivity index (RI), in a population of high-risk pregnant women, initially assessed through traditional risk factors. A prospective single-center observational longitudinal study was conducted, in which 100 women with singleton pregnancy and traditional clinical and medical history risk factors for preeclampsia were enrolled at 24 weeks of gestation. Shortly after study enrollment, all women had their sFlt-1 and PlGF levels and mean uterine artery PI and RI determined. All pregnancies were followed up until delivery. Receiver operating characteristic (ROC) analysis established algorithms based on cutoffs for the prediction of the later development of preeclampsia: PI 1.25 (96.15% sensitivity, 86.49% specificity), RI 0.62 (84.6% sensitivity, 89.2% specificity) and sFlt-1/PlGF ratio 59.55 (100% sensitivity, 89.2% specificity). The sFlt-1/PlGF ratio was the best predictor for preeclampsia, as it displayed the highest area under the curve (AUC) of 0.973. The prediction algorithm for the severe form of preeclampsia, complicated by fetal growth restriction leading to preterm birth, antepartum fetal demise or acute fetal distress with a cerebro-placental ratio of <one consisted of the following cutoffs: PI 1.44 (93.75% sensitivity, 95.24% specificity), RI 0.69 (87.5% sensitivity, 100% specificity) and sFlt-1/PlGF ratio 102.74 (93.75% sensitivity, 95.2% specificity). These algorithms may significantly enhance the prediction accuracy of preeclampsia compared to traditional risk factors. The combination of the sFlt-1/PlGF ratio with mean uterine PI and RI in particular displayed an improved performance in the prediction of severe preeclampsia with the above-mentioned complications, compared to the biochemical markers or uterine Doppler parameters used alone. Therefore, HDP screening strategies should increasingly focus on implementing such algorithms for women who are initially regarded as high risk based on traditional risk factors, in order to properly diagnose HDP and properly limit or manage the later maternal and fetal complications.

Keywords: gestational hypertension; intrauterine growth restriction; prediction; preeclampsia; soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio; uterine Doppler.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Second trimester Doppler ultrasound scan of the uterine artery at 23−24 weeks of gestation. (Left): normal pregnancy—PI and RI values within normal range. (Right): significantly increased values of PI and RI can be noticed in the case of a pregnancy later diagnosed with early-onset preeclampsia.
Figure 2
Figure 2
ROC curve for the most accurate uterine PI cutoff at 24 weeks for preeclampsia prediction.
Figure 3
Figure 3
ROC curve for the most accurate uterine RI cutoff at 24 weeks for preeclampsia prediction.
Figure 4
Figure 4
ROC curve for the most accurate sFlt-1/PlGF ratio value cutoff (59.55) at 24 weeks for preeclampsia prediction.
Figure 5
Figure 5
Comparison of the ROC curves for all three studied parameters—sFlt-1/PlGF is the most accurate parameter for preeclampsia prediction.
Figure 6
Figure 6
Severe preeclampsia prediction strategy: the ROC curve established 1.44 as the best uterine PI cutoff.
Figure 7
Figure 7
Severe preeclampsia prediction strategy: the ROC curve established 0.69 as the best uterine RI cutoff.
Figure 8
Figure 8
Severe preeclampsia prediction strategy: the ROC curve established 102.74 as the sFlt-1/PlGF ratio cutoff.
Figure 9
Figure 9
Graphical comparison of AUC for mean uterine PI, mean uterine RI and sFlt-1/PlGF—mean uterine RI is the best predictor of gestational hypertension.

Similar articles

Cited by

References

    1. Garovic V.D., Dechend R., Easterling T., Karumanchi S.A., McMurtry Baird S., Magee L.A., Rana S., Vermunt J.V., August P., American Heart Association Council on Hypertension et al. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022;79:e21–e41. doi: 10.1161/HYP.0000000000000208. Erratum in Hypertension 2022, 79, e70. - DOI - PMC - PubMed
    1. Khan B., Allah Yar R., Khakwani A.K., Karim S., Arslan Ali H. Preeclampsia Incidence and Its Maternal and Neonatal Outcomes With Associated Risk Factors. Cureus. 2022;14:e31143. doi: 10.7759/cureus.31143. - DOI - PMC - PubMed
    1. Brown M.A., Magee L.A., Kenny L.C., Karumanchi S.A., McCarthy F.P., Saito S., Hall D.R., Warren C.E., Adoyi G., Ishaku S. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310. - PubMed
    1. Espinoza J., Vidaeff A., Pettker C.M., Simhan H. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135:e237–e260. - PubMed
    1. Unger T., Borghi C., Charchar F., Khan N.A., Poulter N.R., Prabhakaran D., Ramirez A., Schlaich M., Stergiou G.S., Tomaszewski M., et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334–1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. - DOI - PubMed